Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Chronic Kidney Disease Market, by Diagnosis
6.1 Introduction
6.2 Blood Test
6.2.1 Market Estimates & Forecast, 2020โ2027
6.3 Urine Test
6.3.1 Market Estimates & Forecast, 2020โ2027
6.4 Imaging Test
6.4.1 Market Estimates & Forecast, 2020โ2027
6.5 Kidney Biopsy
6.5.1 Market Estimates & Forecast, 2020โ2027
7. Global Chronic Kidney Disease Market, by Treatment
7.1 Introduction
7.2 Drugs
7.2.1 Market Estimates & Forecast, 2020โ2027
7.3 Dialysis
7.3.1 Market Estimates & Forecast, 2020โ2027
7.4 Kidney Transplant
7.4.1 Market Estimates & Forecast, 2020โ2027
8. Global Chronic Kidney Disease Market, by Indication
8.1 Introduction
8.2 Type 1 or Type 2 Diabetes
8.2.1 Market Estimates & Forecast, 2020โ2027
8.3 High Blood Pressure
8.3.1 Market Estimates & Forecast, 2020โ2027
8.4 Polycystic Kidney Disease
8.4.1 Market Estimates & Forecast, 2020โ2027
9. Global Chronic Kidney Disease Market, by End-User
9.1 Introduction
9.2 Hospital & Clinics
9.2.1 Market Estimates & Forecast, 2020โ2027
9.3 Diagnostic Centers
9.3.1 Market Estimates & Forecast, 2020โ2027
10. Global Chronic Kidney Disease Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.1 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 U.K.
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
12 Company Profiles
12.1 Abbott
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Siemens
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Beckman Coulter
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 F. Hoffmann-La Roche Ltd
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 ACON Laboratories, Inc.
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Nova Biomedical
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 ARKRAY
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of the Industry
14 Appendix
LIST OF TABLES
Table 1 Chronic Kidney Disease Industry Synopsis, 2020โ2027
Table 2 Global Chronic Kidney Disease Market Estimates and Forecast, 2020โ2027, (USD Million)
Table 3 Global Chronic Kidney Disease Market, by Region, 2020โ2027, (USD Million)
Table 4 Global Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 5 Global Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 6 Global Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 7 Global Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
Table 8 North America Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 9 North America Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 10 North America Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 11 North America Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
Table 12 US Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 13 US Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 14 US Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 15 US Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
Table 16 Canada Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 17 Canada Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 18 Canada Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 19 Canada Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
Table 20 South America Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 21 South America Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 22 South America Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 23 South America Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
Table 24 Europe Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 25 Europe Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 26 Europe Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 27 Europe Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
Table 28 Western Europe Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 29 Western Europe Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 30 Western Europe Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 31 Western Europe Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
Table 32 Eastern Europe Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 33 Eastern Europe Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 34 Eastern Europe Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 35 Eastern Europe Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
Table 36 Asia Pacific Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 37 Asia Pacific Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 38 Asia Pacific Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 39 Asia Pacific Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
Table 40 Middle East & Africa Chronic Kidney Disease Market, by Diagnosis, 2020โ2027, (USD Million)
Table 41 Middle East & Africa Chronic Kidney Disease Market, by Treatment, 2020โ2027, (USD Million)
Table 42 Middle East & Africa Chronic Kidney Disease Market, by Indication, 2020โ2027, (USD Million)
Table 43 Middle East & Africa Chronic Kidney Disease Market, by End-User, 2020โ2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Chronic Kidney Disease Market
Figure 3 Segmentation Market Dynamics for Chronic Kidney Disease Market
Figure 4 Global Chronic Kidney Disease Market Share, by Treatment, 2020
Figure 5 Global Chronic Kidney Disease Market Share, by Indication, 2020
Figure 6 Global Chronic Kidney Disease Market Share, by End-User, 2020
Figure 7 Global Chronic Kidney Disease Market Share, by Region, 2020
Figure 8 North America Chronic Kidney Disease Market Share, by Country, 2020
Figure 9 Europe Chronic Kidney Disease Market Share, by Country, 2020
Figure 10 Asia Pacific Chronic Kidney Disease Market Share, by Country, 2020
Figure 11 Middle East & Africa Chronic Kidney Disease Market Share, by Country, 2020
Figure 12 Global Chronic Kidney Disease Market: Company Share Analysis, 2020 (%)
Figure 13 Abbott: Key Financials
Figure 14 Abbott: Segmental Revenue
Figure 16 Abbott: Geographical Revenue
Figure 17 Siemens: Key Financials
Figure 18 Siemens: Segmental Revenue
Figure 19 Siemens: Geographical Revenue
Figure 20 Beckman Coulter: Key Financials
Figure 21 Beckman Coulter: Segmental Revenue
Figure 22 Beckman Coulter: Geographical Revenue
Figure 23 F. Hoffmann-La Roche Ltd: Key Financials
Figure 24 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 25 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 26 Nova Biomedical: Key Financials
Figure 27 Nova Biomedical: Segmental Revenue
Figure 28 Nova Biomedical: Geographical Revenue
Figure 29 ACON Laboratories, Inc.: Key Financials
Figure 30 ACON Laboratories, Inc.: Segmental Revenue
Figure 31 ACON Laboratories, Inc.: Geographical Revenue
